rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Alan Glicklich

Director

Company insider

Files Form 4 as: Director, CalciMedica; Chief Medical Officer, Chinook Therapeutics.

In numbers

Trades disclosed
23
Buys
0
Sells
2
Bought
$0
Sold
$357K
Companies
2
Companies where not an officer
1
First trade
5 Oct 2020
Last trade
1 Oct 2026
Last filed
5 Oct 2026

Companies traded

Where they are an officer
Chinook TherapeuticsOfficer · last 11 Feb 20220 buys · 2 sells
Everywhere else they filed: board seats, 10% stakes, other companies
CALC CalciMedicaDirector · Biotechnology · last 1 Oct 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 5 Oct 2026CALC CalciMedicaoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
19 Aug 2026filed 21 Aug 2026CALC CalciMedicaoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
19 Aug 2026filed 21 Aug 2026CALC CalciMedicaoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
13 Oct 2025filed 14 Oct 2025CALC CalciMedicaoption or derivative · BiotechnologySEC FORM 4 Code A—937 at $0.00filing
24 Jun 2025filed 26 Jun 2025CALC CalciMedicaoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
24 Jun 2025filed 26 Jun 2025CALC CalciMedicaoption or derivative · BiotechnologySEC FORM 4 Code A—4,166 at $0.00filing
24 Jun 2025filed 26 Jun 2025CALC CalciMedicaoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
24 Jun 2025filed 26 Jun 2025CALC CalciMedicaoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
15 Jan 2025filed 16 Jan 2025CALC CalciMedicaoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
11 Feb 2022filed 14 Feb 2022Chinook TherapeuticsSEC FORM 4 Sold$30K2,391 at $12.74filing
10 Feb 2022filed 14 Feb 2022Chinook Therapeuticsoption or derivativeSEC FORM 4 Code M—5,668 at $0.00filing
10 Feb 2022filed 14 Feb 2022Chinook TherapeuticsSEC FORM 4 Code M—5,668filing
6 Oct 2021filed 8 Oct 2021Chinook Therapeuticsoption or derivativeSEC FORM 4 Code M—7,103 at $0.00filing
6 Oct 2021filed 8 Oct 2021Chinook TherapeuticsSEC FORM 4 Code M—7,103filing
6 Oct 2021filed 8 Oct 2021Chinook TherapeuticsSEC FORM 4 Code F$31K2,489 at $12.37filing
16 Jun 2021filed 17 Jun 2021Chinook Therapeuticsoption or derivativeSEC FORM 4 Code M—20,000 at $0.00filing
16 Jun 2021filed 17 Jun 2021Chinook TherapeuticsSEC FORM 4 Code M$8,40020,000 at $0.42filing
16 Jun 2021filed 17 Jun 2021Chinook TherapeuticsSEC FORM 4 Sold$327K20,000 at $16.35filing
10 Feb 2021filed 12 Feb 2021Chinook Therapeuticsoption or derivativeSEC FORM 4 Code A—50,000 at $0.00filing
10 Feb 2021filed 12 Feb 2021Chinook Therapeuticsoption or derivativeSEC FORM 4 Code A—17,005 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.